Arlington Partners’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-13,776
Closed -$3.87M 40
2025
Q3
$3.87M Sell
13,776
-8,385
-38% -$2.14M 1.34% 55
2025
Q2
$4.85M Sell
22,161
-2,504
-10% -$404K 1.79% 8
2025
Q1
$3.45M Hold
24,665
1.35% 52
2024
Q4
$4.11M Sell
24,665
-2,772
-10% -$492K 1.6% 37
2024
Q3
$4.68M Buy
27,437
+4,497
+20% +$651K 1.83% 6
2024
Q2
$3.24M Sell
22,940
-3,277
-12% -$407K 1.61% 31
2024
Q1
$3.29M Buy
26,217
+1,014
+4% +$116K 1.68% 19
2023
Q4
$2.66M Sell
25,203
-746
-3% -$81.4K 0.76% 48
2023
Q3
$2.75M Sell
25,949
-9,250
-26% -$1.07M 1.13% 34
2023
Q2
$4.19M Sell
35,199
-8,819
-20% -$912K 0.65% 13
2023
Q1
$4.09M Sell
44,018
-8,299
-16% -$728K 0.58% 11
2022
Q4
$4.28M Buy
52,317
+101
+0.2% +$7.68K 0.68% 12
2022
Q3
$3.19M Buy
52,216
+571
+1% +$41.8K 1.28% 13
2022
Q2
$3.61M Buy
51,645
+1,218
+2% +$89.2K 1.2% 15
2022
Q1
$4.17M Sell
50,427
-5,498
-10% -$445K 1.18% 16
2021
Q4
$4.88M Sell
55,925
-4,298
-7% -$404K 1.31% 16
2021
Q3
$5.25M Buy
60,223
+6,437
+12% +$569K 1.51% 16
2021
Q2
$4.19M Sell
53,786
-964
-2% -$75.5K 1.45% 14
2021
Q1
$3.84M Buy
54,750
+4,505
+9% +$292K 1.41% 13
2020
Q4
$3.25M Buy
50,245
+673
+1% +$40.1K 1.5% 14
2020
Q3
$2.96M Hold
49,572
1.62% 15
2020
Q2
$2.74M Buy
49,572
+2,978
+6% +$158K 1.54% 15
2020
Q1
$2.25M Buy
46,594
+37,372
+405% +$1.93M 1.17% 19
2019
Q4
$489K Buy
9,222
+2,252
+32% +$124K 0.3% 27
2019
Q3
$384K Sell
6,970
-42,100
-86% -$2.33M 0.24% 30
2019
Q2
$2.8M Buy
49,070
+38,275
+355% +$2.07M 1.25% 17
2019
Q1
$580K Sell
10,795
-31,710
-75% -$1.62M 0.41% 23
2018
Q4
$1.92M Buy
42,505
+625
+1% +$30K 1.25% 14
2018
Q3
$2.16M Buy
41,880
+4,260
+11% +$207K 1.52% 13
2018
Q2
$1.66M Hold
37,620
1.57% 13
2018
Q1
$1.72M Buy
37,620
+3,360
+10% +$167K 1.62% 13
2017
Q4
$1.62M Buy
+34,260
New +$1.68M 1.67% 13

Other funds holding ORCL

Arlington Partners's ORCL Position: Q4 2025 in Review

Arlington Partners sold out of Oracle (ORCL) in Q4 2025, closing a stake of 13,776 shares — an estimated $3.87M sold.

Arlington Partners first reported a position in ORCL in Q4 2017 and held it in 32 quarters. The position peaked at $5.25M in Q3 2021. 3,758 funds tracked by Wall St. Rank hold ORCL as of Q4 2025.

  • Arlington Partners reported no remaining Oracle position as of Q4 2025 after selling out during the quarter.
  • Arlington Partners sold 13,776 Oracle shares in Q4 2025, an estimated $3.87M.
  • Arlington Partners first reported a position in Oracle in Q4 2017 and held it in 32 quarters.
  • Arlington Partners's Oracle position peaked at $5.25M in Q3 2021.
  • 3,758 funds tracked by Wall St. Rank held Oracle as of Q4 2025.

Based on Arlington Partners's 13F filing for Q4 2025, filed 29 Jan 2026.